Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury

US9649347B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9649347-B2
Application numberUS-201514980606-A
CountryUS
Kind codeB2
Filing dateDec 28, 2015
Priority dateNov 15, 2013
Publication dateMay 16, 2017
Grant dateMay 16, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An anti-oxidative Lactobacillus rhamnosus CCFM1107 can relieve chronic alcoholic liver injury, and L. rhamnosus CCFM1107 can be used in preparing dairy products as starter culture. The dairy products of this invention include milk, milk powder, milk capsules or fermented milk containing L. rhamnosus CCFM1107. It has strong abilities of anti-oxidation, scavenging diphenyl picrylhydrazyl (DPPH) radical and hydroxyl radical, inhibiting lipid peroxidation, tolerating cholate, chlorine sodium and pH, and can improve liver function and antioxidative index, lower serum endotoxin level and regulate intestinal flora distribution, thus effectively relieving alcoholic liver injury of mice.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a dairy composition, which comprises: i) inoculating sterilized skim milk with Lactobacillus rhamnosus , and incubating at 37° C. for 14-16 h, which forms as curd; ii) inoculating sterilized skim milk with the curd of step i), and incubating at 37° C. for 14-16 h, which results in curd; iii) inoculating sterilized skim milk with the curd of step ii), and incubating at 37° C. for 14-16 h, which forms curd that named as a mother starter; iv) inoculating sterilized skim milk with the mother starter, and incubating at 37° C. for 14-16 h, which forms curd as a starter culture which contains 1-3×10 9 CFU/ml bacteria; v) mixing the starter culture with a sterilized raw milk which contains at least 10 6 CFU/ml Lactobacillus rhamnosus , and storing at a refrigerator, characterized in that the Lactobacillus rhamnosus is Lactobacillus rhamnosus CCFM1107, deposited at the General Microbiology Culture Collection Center of China Committee for Culture Collection of Microorganisms under accession number CGMCC5496. 2. The method according to claim 1 , which further comprises: a) mixing the raw milk with the starter culture, incubating at 37° C. for 12-18 h which yields fermented milk after the step iv) of claim 1 ; then b) mixing the fermented milk and the sterilized raw milk, homogenizing, vacuum-concentrating and spray-drying which yields milk powders which are optionally capsulated as milk capsules. 3. The method according to claim 1 , wherein the raw milk is one or more kinds of milk selected from skim milk, fresh milk, or reconstituted milk wherein the milk is selected from cow's milk, goat's milk or mare's milk. 4. The method according to claim 1 , which further comprises: c) adding 3-5% of the starter culture and 3-5% of commercial culture by volume into the sterilized raw milk after the step iv) of claim 1 ; and chi) homogenizing, fermenting at 37° C. until the concentration of lactic acid is up 0.6-0.7%; iii) cooling and storing in a refrigerator. 5. The method according to claim 4 , wherein the commercial culture contains Lactobacillus bulgaricus or/and Streptococcus thermophilus.

Assignees

Inventors

Classifications

  • Human Necessities · mapped topic

  • Bacteria or derivatives thereof, e.g. probiotics · CPC title

  • characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp. · CPC title

  • Bacteria; Culture media therefor · CPC title

  • Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9649347B2 cover?
An anti-oxidative Lactobacillus rhamnosus CCFM1107 can relieve chronic alcoholic liver injury, and L. rhamnosus CCFM1107 can be used in preparing dairy products as starter culture. The dairy products of this invention include milk, milk powder, milk capsules or fermented milk containing L. rhamnosus CCFM1107. It has strong abilities of anti-oxidation, scavenging diphenyl picrylhydrazyl (D…
Who is the assignee on this patent?
Univ Jiangnan
What technology area does this patent fall under?
Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).